Carroll J Martin's Form 4 filing
Esperion Therapeutics, Inc. (ESPR) · filed May 11, 2023
- Accession no.
- 0001628280-23-017563
- Filed
- May 11, 2023
- Trade date
- May 10-11, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $48.8K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Carroll J MartinCIK 0001279901 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 10, 2023 | Common Stock | PPurchaseAcquired | +8,409 | $1.49 | +$12,529.41 | 13,409 | Direct | |
| May 11, 2023 | Common Stock | PPurchaseAcquired | +23,091 | $1.57 | +$36,252.87 | 36,500 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.